The Real World Study of Apatinib for Gastric Cancer Treatment in Henan Province

Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer

NCT03598348 ·Status: UNKNOWN ·Phase: PHASE3

Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric Cancer

NCT03950141 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer

NCT03255811 ·Status: UNKNOWN ·Phase: NA

Apatinib for the Elderly Advanced Gastric Cancer

NCT03104283 ·Status: COMPLETED ·Phase: PHASE2

Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer

NCT02537171 ·Status: UNKNOWN ·Phase: PHASE3

Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial

NCT03531931 ·Status: UNKNOWN

Research On the Optimized Treatment Method For Apatinib's Cure Of Advanced Gastric Cancer

NCT03334591 ·Status: UNKNOWN ·Phase: PHASE2

Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer

NCT02509806 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer

NCT02764268 ·Status: COMPLETED ·Phase: NA

Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer

NCT02697838 ·Status: UNKNOWN ·Phase: PHASE2

Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.

NCT03144843 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer

NCT04338438 ·Status: COMPLETED ·Phase: PHASE2

Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer

NCT03954756 ·Status: UNKNOWN ·Phase: PHASE2

Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer

NCT03219593 ·Status: UNKNOWN ·Phase: PHASE2

An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer

NCT02668380 ·Status: UNKNOWN

The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer

NCT03889626 ·Status: UNKNOWN ·Phase: PHASE3

A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer

NCT03271073 ·Status: UNKNOWN ·Phase: PHASE2

PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma

NCT04006821 ·Status: UNKNOWN ·Phase: PHASE2

Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer

NCT01512745 ·Status: COMPLETED ·Phase: PHASE3

Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer

NCT02525237 ·Status: UNKNOWN ·Phase: PHASE2

The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer

NCT02485015 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy

NCT02776527 ·Status: UNKNOWN ·Phase: PHASE4

Apatinib with Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma of the Stomach

NCT04863430 ·Status: WITHDRAWN ·Phase: PHASE2

Study of the Apatinib Combine With POF Versus POF in Gastric Cancer

NCT04121039 ·Status: UNKNOWN ·Phase: PHASE2

A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors

NCT05464875 ·Status: RECRUITING